Table 1.
Experimentally validated melanoma-associated lncRNAs in Homo sapiens
| Melanoma-associated lncRNAs | |||||
|---|---|---|---|---|---|
| LncRNA name | NCBI accession | Alias | Dysfunction Type | Function | PMID |
| BANCR | NR_047671 | LINC00586 | Regulation | Cell migration | 22581800 |
| CASC15 | NR_015410 | LINC00340; CANT; lnc-SOX4–1 | Regulation | Progression and phenotype Switching | 26016895 |
| CDKN2B-AS1 | NR_047538 | PCAT12; CDKN2B-AS; NCRNA00089; p15AS; ANRIL; CDKN2BAS; CDKN2B-AS | Regulation | Epigenetic silencing | 27461581 |
| GAS5 | NR_002578 | NCRNA00030; SNHG2 | Regulation | Cell migration and invasion | 26846479 |
| H19 | NR_131223 | ASM1; WT2; ASM; BWS; LINC00008; NCRNA00008; D11S813E | Expression | Pathogenesis of melasma | 19968822 |
| HOTAIR | NR_047528 | NCRNA00072; HOXC11-AS1; HOXAS; HOXC-AS4 | Regulation | Cell migration and invasion | 23862139 |
| LINC00032 | NR_026679 | C9orf14; NCRNA00032 | Mutation | Nevus development | 17099875 |
| LINC00673 | NR_036488 | HILNC75; LUCAIR1; SLNCR1; HI-LNC75; SLNCR; ERRLR01 | Expression | Invasion | 27210747 |
| MALAT1 | NR_002847 | NEAT2; LINC00047; NCRNA00047; HCN; PRO2853 | Expression | Cell migration | 24892958 |
| MGC16025 | NR_026664.1 | LOC85009; MELOE | Expression | Immunosurveillance | 27486971 |
| MIR31HG | NR_027054 | LncHIFCAR; hsa-lnc-31 | Regulation | Transcriptional regulator | 25908244 |
| PTENP1 | NR_023917.1 | PTEN-rs; PTH2; PTENpg1; PTEN2; psiPTEN | Regulation | Tumor suppressor | 21833010 |
| SAMMSON | NR_110000 | LINC01212 | Regulation | Cell growth and survival | 27008969 |
| SNHG5 | NR_003038 | C6orf160; LINC00044; NCRNA00044; U50HG | Expression | Pathogenesis of metastatic melanoma | 26440365 |
| SPRY4-IT1 | NR_131221 | SPRIGHTLY | Regulation | Cell invasion & proliferation | 25344859 |
| TUG1 | NR_002321 | LINC00080; TI-227H; NCRNA00080 | Regulation | Tumor growth and metastasis | 29543785 |
| UCA1 | NR_015379 | LINC00178; UCAT1; CUDR; onco-lncRNA-36; NCRNA00178 | Expression | Cell migration | 24892958 |